Navigation Links
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
Date:5/15/2013

results of selumetinib versus temozolomide in uveal melanoma (Abstract # CRA9003) will lift on Saturday, June 1 at 6:30 a.m. CDT.  ASCO's embargo for the remaining abstracts in this release will lift on Wednesday, May 15 at 6:00 p.m. EDT.  All abstracts can be accessed through the ASCO website, http://abstract.asco.org/.  After the presentations and posters are public, they will be available as PDFs on Array's website at www.arraybiopharma.com.

*The MEK162 abstract submitted only incorporates data as of early 2013.  Up-to-date clinical data will be included during the presentation at the Annual Meeting.

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company and currently expects significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.
Novartis expects to begin Phase 3 trials evaluating Array-invented MEK162 in NRAS- and BRAF-mutant melanoma in 2013.  In addition, Array expects to begin a Phase 3 trial evaluating MEK162 in low-grade serous ovarian cancer under the license agreement with Novartis in 2013.  AstraZeneca expects to begin Phase 3 or pivotal registration trials with selumetinib (an Array-invented drug) in non-small cell lung cancer and thyroid cancer during the second half of 2013.  Three other Array-invented drugs are also approaching Phase 3 or pivotal trial decisions which are expected by the end of 2013. These include Array's wholly-owned drugs, ARRY-520 and ARRY-614, and one partnered program, danoprevir (with InterMune/Roche).  For more information on Array, please go to www.arraybiopharma.com.

(Logo: 
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
2. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
3. New Versa HD System Tops Elektas Comprehensive Array of Cancer Management Solutions at 2nd ESTRO Forum
4. Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
5. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
6. Array BioPharma To Present At The Cowen Annual Health Care Conference
7. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
10. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
11. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... /PRNewswire-iReach/ -- "North America Orthopedic Braces and Supports Market ... North America Orthopedic Braces and Supports market. The report ... (in units) and average price data (in US dollars), ... Supports , Ankle Braces and Supports , ... and Supports. Photo - ...
(Date:7/24/2014)... -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) today ... 2014. Three Months Ended 06/30/14Three Months Ended 06/30/13 ,  Percentage ... 51% Non-GAAP Net Sales , $278.8 Million , $196.1 ... , $1.12 , 37% Non-GAAP Diluted ... 37%  Six Months Ended 06/30/14Six Months Ended 06/30/13 , ...
(Date:7/24/2014)... 24, 2014  To help health care organizations ... could impact patient care and the bottom line, ... , "Innovations in Cardiovascular Devices."  ... and details on promising new technologies that can ... how these options impact the supply chain.   According ...
Breaking Medicine Technology:North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5Questcor Reports Record Second Quarter Financial Results 2Questcor Reports Record Second Quarter Financial Results 3Questcor Reports Record Second Quarter Financial Results 4Questcor Reports Record Second Quarter Financial Results 5Questcor Reports Record Second Quarter Financial Results 6Questcor Reports Record Second Quarter Financial Results 7Questcor Reports Record Second Quarter Financial Results 8Questcor Reports Record Second Quarter Financial Results 9Questcor Reports Record Second Quarter Financial Results 10Questcor Reports Record Second Quarter Financial Results 11Questcor Reports Record Second Quarter Financial Results 12Questcor Reports Record Second Quarter Financial Results 13Questcor Reports Record Second Quarter Financial Results 14Questcor Reports Record Second Quarter Financial Results 15Questcor Reports Record Second Quarter Financial Results 16Questcor Reports Record Second Quarter Financial Results 17Questcor Reports Record Second Quarter Financial Results 18Questcor Reports Record Second Quarter Financial Results 19Questcor Reports Record Second Quarter Financial Results 20Questcor Reports Record Second Quarter Financial Results 21Questcor Reports Record Second Quarter Financial Results 22Questcor Reports Record Second Quarter Financial Results 23Questcor Reports Record Second Quarter Financial Results 24Questcor Reports Record Second Quarter Financial Results 25Questcor Reports Record Second Quarter Financial Results 26Questcor Reports Record Second Quarter Financial Results 27Questcor Reports Record Second Quarter Financial Results 28New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3
...  TSH testing, the gold standard in hypothyroid diagnosis, may ... new article titled Hormone Replacement Therapy in ... Questions for the Future. Estrogen, Progesterone, Testosterone, and Thyroid ... article, independently written and published, is a broad study ...
... Jan. 2, 2012 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... call on Tuesday, January 3, 2012 at 8:30 a.m. Eastern ... ongoing patent litigation with Genentech, Inc., a member of the ... Conference Call InformationDomestic Dial-in Number: (888) 660-6127 International Dial-in Number: ...
Cached Medicine Technology:Studies Show That TSH Is Unreliable in the Diagnosis of Hypothyroidism According to Article Contributed by Kent Holtorf, M.D. in Clinical Geriatrics 2Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation 2
(Date:7/24/2014)... (PRWEB) July 24, 2014 In ... Tuesday, President Obama cited the Atlanta BeltLine Workforce ... programs from across the country ( http://www.whitehouse.gov/ready-to-work ... an essential pillar of U.S. economic strategy and ... , “This recognition from President Obama highlights the ...
(Date:7/24/2014)... University, working with high-throughput data generated by breast ... devised a computational method to determine how gene ... malignant and as they respond to potential cancer ... interact with each other in laboratory-grown cells is ... online journal PLOS Computational Biology . , ...
(Date:7/24/2014)... rare procedure occasionally performed during Jewish circumcisions that involves ... herpes simplex virus type 1 (HSV-1) transmissions documented in ... conducted by Penn Medicine researchers and published online ... Society found. The reviewers, from Penn,s ... in New York, Canada and Israel. , The practiceknown ...
(Date:7/24/2014)... Lynn E. Taylor, M.D., director of The ... the July, 2014 Rhode Island Medical Journal ... eliminating hepatitis c virus infection (hep c or ... capacity to address other health challenges, and improve ... the United States, Taylor says, include lack of ...
(Date:7/24/2014)... July 24, 2014 Plaintiffs in ... ) against the manufacturer of Delatestryl, alleging they ... with the low testosterone injection, Bernstein Liebhard LLP ... in the Ontario Superior Court of Justice on ... low testosterone therapy is associated with an increased ...
Breaking Medicine News(10 mins):Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 2Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 3Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 4Health News:President Cites Atlanta BeltLine Workforce Partnership in Healthcare as National Model 5Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Link between ritual circumcision procedure and herpes infection in infants examined 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 2Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 3Health News:Miriam Hospital physician advocates awareness, collaboration to combat peaking hep C virus 4Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuit News: Canadian Plaintiffs File Class Action Lawsuit Against Manufacturer of Delatestryl Testosterone Injection, Bernstein Liebhard LLP Reports 3
... System in U.S. receives a low score (66 out ... first national scoring system of the 18-member Commonwealth Fund ... in promoting better health care systems for low-income and ... rankings were based on the scoring in various areas ...
... recent study reports that while teachers and students prefer ... and abortion rates especially in UK schools. When teen ... many influencing factors – the officials said. The study, ... was published in the British Medical Journal, covered about ...
... Fr Angelo D'Agostino SJ, a Jesuit priest, well-known for his ... Monday at the age of 80. ,He was the ... centre for abandoned HIV-positive children. ,Fr Joachim Omolo Ouko ... tribute to Fr Angelo D'Agostino SJ ,He said, "Father D'Agostino ...
... Ovarian cancer continues to be a stealthy killer in Australia ... in the advanced stages. Reports reveal that less than half ... beyond five years. Only about 42% of patients survive when ... a Federal government report. The survival rate is low for ...
... in how insects develop from larvae to adults have ... failure// to be effective in preventing and reducing cardiac ... Davis research published in the early online edition of ... ,The research, led by cardiologist and cell biologist Nipavan ...
... woman and a mother of two children died of breast cancer ... in Sheffield. //Dr.John Philip was not qualified to read mammograms according ... Trust, David Jackson. ,The woman who is identified as ... Philip told her that she was normal. When she went for ...
Cached Medicine News:Health News:Insect Protein Effective for Treating Heart Enlargement, Arrythmias 2
... TraceMasterVue is a cutting-edge ... rich, thin-client functionality and convenient, ... clinical, administrative and information technology ... productivity, lower costs, and improved ...
... testing within reach of virtually any facility...from ... most advanced cardiology hospital. This PC-based system ... options for a Philips ergonomic stress cart ... StressVue is designed to interface with the ...
A component of the 3M Littmann Electronic Stethoscope Model 4000...
... with the challenge of,controlling costs while ... patient data,management is critical. INFINITY modular,patient ... important clinical information,wherever you are in ... concept,makes your job easier. You can ...
Medicine Products: